Since the discovery that IDH1/2 mutations confer a significantly better prognosis in astrocytomas, much work has been done to identify other molecular signatures to help further stratify lower-grade astrocytomas …

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...